TSVT Insider Trading Activity and SEC Form 4 Filings
TSVT insider trading summary
No open-market insider purchases or sales of 2seventy bio, Inc. (TSVT) have been reported on SEC Form 4 in the past 12 months.
Latest TSVT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2025 | William D Baird III | President and CEO | Sell | $25K (5,092 @ $4.95) |
| Mar 17, 2025 | Victoria Eatwell | Chief Financial Officer | Sell | $13K (2,592 @ $4.95) |
| Mar 17, 2025 | Jessica Snow | Chief Operating Officer | Sell | $11K (2,298 @ $4.95) |
| Mar 11, 2025 | Kynam Global Healthcare Master Fund, LP | 10% Owner | Sell | $25.4M (5,142,111 @ $4.93) |
| Mar 11, 2025 | Kynam Global Healthcare Master Fund, LP | 10% Owner | Sell | $29.4M (5,953,825 @ $4.93) |
| Mar 11, 2025 | Kynam Capital Management, LP | 10% Owner | Sell | $29.4M (5,953,825 @ $4.93) |
| Mar 11, 2025 | Kynam Capital Management GP, LLC | 10% Owner | Sell | $25.4M (5,142,111 @ $4.93) |
| Mar 11, 2025 | Kynam Fund GP, LLC | 10% Owner | Sell | $25.4M (5,142,111 @ $4.93) |
| Mar 11, 2025 | Kynam Fund GP, LLC | 10% Owner | Sell | $29.4M (5,953,825 @ $4.93) |
| Mar 11, 2025 | Kynam Capital Management GP, LLC | 10% Owner | Sell | $29.4M (5,953,825 @ $4.93) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.